UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
_____________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 9, 2022
_____________________________
(Exact name of registrant as specified in its charter)
_____________________________
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, include area code) (212 ) 206-0763
N/A
(Former Name or Former Address, if Changed Since Last Report)
_____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbols | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 9, 2022, The Vita Coco Company, Inc. (the “Company”) issued a press release announcing financial results for the three and nine months ended September 30, 2022 and other matters described in the press release. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
Exhibit No. | Description | ||||
99.1 | |||||
104 | Cover Page Interactive Data File (embedded with Inline XBRL document) | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE VITA COCO COMPANY, INC. | ||||||||
Date: November 9, 2022 | By: | /s/ Rowena Ricalde | ||||||
Name: Rowena Ricalde | ||||||||
Title: Interim Chief Financial Officer | ||||||||
Exhibit 99.1
THE VITA COCO COMPANY REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
Net Sales of $124 Million, up 7% from Prior Year Driven by Strong 14% Growth of Vita Coco Coconut Water
Gross Margin of 26.3% Represents Continued Sequential Improvement over 90 Basis Points from Prior Quarter
Net Income was $7 Million, 5.9% of Net Sales, an Improvement of over 450 Basis Points from Prior Quarter
Adjusted EBITDA1 was 9.5% of Net Sales, an Improvement of over 300 Basis Points from Prior Quarter
NEW YORK, November 9, 2022 (GLOBE NEWSWIRE) - - The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the "Company”), a leading high-growth platform of better-for-you beverage brands, today announced financial results for the third quarter ended September 30, 2022.
Third Quarter 2022 Highlights Compared to Prior Year Period
•Net sales grew 7% to $124 million driven by strong 14% growth of Vita Coco Coconut Water despite significant out-of-stocks on certain flavored coconut water SKUs and a negative foreign currency impact on our reported International net sales.
•Gross profit was $33 million, a decrease of $6 million, or 26% of net sales, representing a sequential improvement of over 90 basis points from the second quarter of 2022 and an improvement of 650 basis points from the first quarter, compared to 33% of net sales in the prior year period, with the decrease driven by higher year-over-year transportation costs.
•Net income attributable to shareholders was $7 million, or $0.13 per diluted share, for the third quarter of 2022, compared to net income of $13 million, or $0.24 per diluted share, in the third quarter of 2021.
•Non-GAAP adjusted EBITDA1 was $12 million compared to $21 million, down $9 million due to higher transportation and ongoing incremental public company costs.
2022 Year-To-Date Highlights Compared to Prior Year Period
•Net sales grew 15% to $336 million driven by strong 22% growth of Vita Coco Coconut Water which continues to be the largest contributor to growth on a consolidated basis.
•Gross profit was $81 million, a decrease of $11 million, or 24% of net sales, compared to 31% of net sales in the prior year period, with the decrease driven by higher year-over-year transportation costs.
•Net income attributable to shareholders was $11 million, or $0.19 per diluted share, compared to net income of $22 million, or $0.42 per diluted share, in the prior year period.
•Non-GAAP adjusted EBITDA1 was $16 million, compared to $36 million, with the decrease primarily driven by higher transportation and ongoing incremental public company costs.
Michael Kirban, the Company's Co-founder and Executive Chairman, stated, "I am very proud of our teams’ performance during a challenging supply chain environment, and I'm especially happy with our strong Vita Coco Coconut Water net revenue growth of 14% in the third quarter. On a two-year basis, our third quarter Vita Coco Coconut Water net sales grew 58% over third quarter 2020, and grew 63% for the nine months year-to-date versus the same period in 2020, demonstrating the health of our brands. In 2023, we expect continued strong growth on our Vita Coco Coconut Water net sales, improvement in our gross margins and substantial progress back toward our long-term adjusted EBITDA target of the high teens as a percentage of sales. We are committed to our long-term ambition to create and maintain category leading brands in the broader, better-for you, functional beverage segment."
Martin Roper, the Company’s Chief Executive Officer, said, “We are pleased with our results, particularly our record net revenue, despite the lost sales from flavored coconut water out-of-stocks and a headwind from foreign exchange
translation. Gross margins benefited from our second quarter pricing actions and a higher proportion of Vita Coco Coconut Water sales relative to private label, which was offset by higher average ocean container costs than prior quarters. We are happy that our brand remains very healthy and feedback from our retail customers on our key 2023 commercial initiatives has been positive. Based on ocean freight rates we are currently being offered, we believe the worst of the cost spike is likely behind us, and the potential margin upside in 2023 and beyond could be significant."
Third Quarter 2022 Consolidated Results
Net sales increased $8 million, or 7%, to $124 million for the third quarter ended September 30, 2022, compared to $116 million for the third quarter ended September 30, 2021. The increase in net sales was driven by increased case equivalent ("CE") volumes coupled with some benefits from net pricing actions.
Strong top line growth driven by the continued underlying strength of our Vita Coco brand was offset by increased transportation costs primarily due to the global shipping cost pressures. As a result, gross profit was $33 million for the third quarter of 2022, which was down $6 million compared to the third quarter of 2021. Gross margin of 26% in the third quarter represented a sequential improvement of over 90 basis points from the second quarter, decreasing from 33% in the same period last year.
Selling, general and administrative expenses in the third quarter of 2022 were $24 million, compared to $21 million in the same prior year period. The increase was largely due to higher marketing and ongoing public company costs, including personnel related expenses and insurance.
Net income attributable to shareholders was $7 million, or $0.13 per diluted share, for the third quarter of 2022, compared to net income of $13 million, or $0.24 per diluted share, in the third quarter of 2021. Net income was positively impacted by a non-cash mark-to-market gain in fair value on foreign currency hedges of $1 million versus a loss of $2 million last year.
Adjusted EBITDA1 for the third quarter of 2022 was $12 million, compared to $21 million in the third quarter of 2021. The decrease in adjusted EBITDA1 was primarily driven by higher transportation costs and incremental public company costs.
Balance Sheet
As of September 30, 2022, the Company had cash and cash equivalents of $21 million and $10 million of debt under a revolving credit facility, compared to $29 million and zero, respectively as of December 31, 2021. The decrease in net cash was primarily driven by working capital seasonality due to significantly increased accounts receivables. Inventories as of September 30, 2022 totaled $74 million compared to $75 million as of December 31, 2021. On September 30, 2022, there were 55,922,992 shares of common stock outstanding.
Fiscal Year 2022 Full Year Outlook
The Company is revising its full year 2022 guidance:
•Expect net sales in the range of $422-427 million, representing a growth of approximately 11-12% compared to fiscal year 2021.
•Anticipate full year gross margins in the mid 20%’s due to continued elevated transportation costs, partially offset by the benefit of higher net pricing and efficiency initiatives. Expect gross margin improvement for the fourth quarter relative to the third quarter.
•Forecast adjusted EBITDA2 in the range of $20-22 million reflecting volume and pricing growth offset by higher than normal transportation costs and increased public company costs.
Footnotes:
(1)Adjusted EBITDA represents earnings before income, taxes, depreciation, and amortization as adjusted for certain items as set forth in the reconciliation table of U.S. GAAP to non-GAAP information and is a measure calculated and presented on the basis of methodologies other than in accordance with GAAP. Please refer to the Use of Non-GAAP Financial Information herein for further discussion and reconciliation of this measure to GAAP measures.
(2) GAAP Net Income 2022 outlook is not provided due to the inherent difficulty in quantifying certain amounts due to a variety of factors including the unpredictability in the movement in foreign currency rates, as well as future charges or reversals outside of the normal course of business.
Conference Call and Webcast Details
The Vita Coco Company will host a conference call and webcast at 8:30 a.m. ET today to discuss these results. To participate in the live earnings call and question and answer session, please register at https://register.vevent.com/register/BIc2fd8e0d9f844c17a9213d754588280c and dial-in information will be provided directly to you. A slide presentation to support the webcast, and the live audio webcast will be accessible in the “Events” section of the Company’s Investor Relations website at https://investors.thevitacococompany.com. An archived replay of the webcast will be available shortly after the live event has concluded.
About The Vita Coco Company
The Vita Coco Company was co-founded in 2004 by Chairman Michael Kirban and Ira Liran. Pioneers in the functional beverage category, The Vita Coco Company’s brands include the leading coconut water, Vita Coco; clean energy drink Runa; sustainable enhanced water, Ever & Ever; and protein-infused water, PWR LIFT. With its ability to harness the power of people and plants, and balance purpose and profit, The Vita Coco Company has created a modern beverage platform built for current and future generations.
The company is a B Corp™ and is incorporated as a Public Benefit Corporation in Delaware.
Contacts
Investor:
ICR, Inc.
investors@thevitacococompany.com
Use of Non-GAAP Financial Measures
In addition to disclosing results determined in accordance with U.S. GAAP, the Company also discloses certain non-GAAP results of operations, including, but not limited to, Adjusted EBITDA, that include certain adjustments or exclude certain charges and gains that are described in the reconciliation table of U.S. GAAP to non-GAAP information provided at the end of this release. These non-GAAP measures are a key metric used by management and our board of directors to assess our financial performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance and because we believe it is useful for investors to see the measures that management uses to evaluate the Company. In addition, we believe the presentation of these measures is useful to investors for period-to-period comparisons of results as the items described below in the reconciliation tables do not reflect ongoing operating performance.
These measures are not in accordance with, or an alternative to, U.S. GAAP, and may be different from non-GAAP measures used by other companies. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces its usefulness as a comparative measure. Investors should not rely on any single financial measure when evaluating our business. This information should be considered as supplemental in nature and is not meant as a substitute for our operating results in accordance with U.S. GAAP. We recommend investors review the U.S. GAAP financial measures included in this earnings release. When viewed in conjunction with our U.S. GAAP results and the accompanying reconciliations, we believe these non-GAAP measures provide greater transparency and a more complete understanding of factors affecting our business than U.S. GAAP measures alone.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including but not limited to, statements regarding our future financial and operating performance, including our GAAP and non-GAAP guidance, our strategy, projected costs, prospects, expectations, plans, objectives of management, supply chain predictions and expected net sales and category share growth.
The forward-looking statements in this release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond the Company’s control. These
factors include, but are not limited to, those discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended on December 31, 2021 filed with the U.S. Securities and Exchange Commission ("SEC") on March 14, 2022 and in our Quarterly Reports on Form 10-Q for the quarters ended on March 31, 2022 and June 30, 2022 filed with the SEC on May 13, 2022 and August 11, 2022 and our other filings with the SEC as such factors may be updated from time to time and which are accessible on the SEC’s website at www.sec.gov and the Investor Relations page of our website at www.vitacoco.com. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.
Website Disclosure
We intend to use our websites, vitacoco.com and investors.thevitacococompany.com, as a means for disclosing material non-public information and for complying with the SEC's Regulation FD and other disclosure obligations.
THE VITA COCO COMPANY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(Amounts in thousands, except share data)
| September 30, 2022 | December 31, 2021 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 21,211 | $ | 28,690 | |||||||
Accounts receivable, net of allowance of $1,565 at September 30, 2022, and $1,301 at December 31, 2021 | 65,717 | 47,195 | |||||||||
| Inventory | 74,459 | 75,360 | |||||||||
| Supplier advances | 1,519 | 1,170 | |||||||||
| Derivative assets | 5,080 | 126 | |||||||||
| Assets held for sale | 503 | — | |||||||||
| Prepaid expenses and other current assets | 22,368 | 20,718 | |||||||||
| Total current assets | 190,857 | 173,259 | |||||||||
| Property and equipment, net | 2,014 | 2,473 | |||||||||
| Goodwill | 7,791 | 7,791 | |||||||||
| Intangible assets, net | 7,019 | 7,934 | |||||||||
| Supplier advances | 4,878 | 2,808 | |||||||||
| Deferred tax assets, net | 1,091 | 1,265 | |||||||||
| Other assets | 4,728 | 1,954 | |||||||||
| Total assets | 218,378 | 197,484 | |||||||||
| Liabilities and Stockholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | 17,353 | 28,338 | |||||||||
| Accrued expenses and other current liabilities | 45,950 | 42,399 | |||||||||
| Notes payable, current | 24 | 28 | |||||||||
| Derivative liabilities | 1,735 | 3,197 | |||||||||
| Total current liabilities | 65,062 | 73,962 | |||||||||
| Credit facility | 9,500 | — | |||||||||
| Notes payable | 30 | 48 | |||||||||
| Other long-term liabilities | 2,173 | 301 | |||||||||
| Total liabilities | 76,765 | 74,311 | |||||||||
| Stockholders’ equity: | |||||||||||
Common stock, $0.01 par value; 500,000,000 shares authorized; 62,129,192 and 61,764,582 shares issued at September 30, 2022 and December 31, 2021, respectively; 55,922,992 and 55,558,382 shares outstanding at September 30, 2022 and December 31, 2021, respectively | 621 | 618 | |||||||||
| Additional paid-in capital | 143,095 | 134,730 | |||||||||
| Retained earnings | 57,993 | 47,369 | |||||||||
| Accumulated other comprehensive loss | (1,168) | (616) | |||||||||
| Treasury stock, 6,206,200 shares at cost as of September 30, 2022, and December 31, 2021. | (58,928) | (58,928) | |||||||||
| Total stockholders’ equity attributable to The Vita Coco Company, Inc. | 141,613 | 123,173 | |||||||||
| Total liabilities and stockholders’ equity | $ | 218,378 | $ | 197,484 | |||||||
THE VITA COCO COMPANY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(Amounts in thousands, except for share and per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
| Net sales | $ | 124,043 | $ | 115,669 | $ | 335,796 | $ | 292,929 | |||||||||||||||
| Cost of goods sold | 91,467 | 77,168 | 254,868 | 201,368 | |||||||||||||||||||
| Gross profit | 32,576 | 38,501 | 80,928 | 91,561 | |||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
| Selling, general and administrative | 23,960 | 20,675 | 73,018 | 61,897 | |||||||||||||||||||
| Income (Loss) from operations | 8,616 | 17,826 | 7,910 | 29,664 | |||||||||||||||||||
| Other income (expense) | |||||||||||||||||||||||
| Unrealized gain/(loss) on derivative instruments | 952 | (1,964) | 6,416 | 1,250 | |||||||||||||||||||
| Foreign currency gain/(loss) | (364) | (483) | (508) | (2,013) | |||||||||||||||||||
| Interest income | 20 | 31 | 30 | 104 | |||||||||||||||||||
| Interest expense | (130) | (127) | (213) | (319) | |||||||||||||||||||
| Total other income (expense) | 478 | (2,543) | 5,725 | (978) | |||||||||||||||||||
| Income before income taxes | 9,094 | 15,283 | 13,635 | 28,686 | |||||||||||||||||||
| Income tax expense | (1,836) | (2,296) | (3,011) | (6,277) | |||||||||||||||||||
| Net income | 7,258 | 12,987 | 10,624 | 22,409 | |||||||||||||||||||
| Net income/(loss) attributable to noncontrolling interest | — | (3) | — | (23) | |||||||||||||||||||
| Net income attributable to The Vita Coco Company, Inc. | $ | 7,258 | $ | 12,990 | $ | 10,624 | $ | 22,432 | |||||||||||||||
| Net income attributable to The Vita Coco Company, Inc. per common share | |||||||||||||||||||||||
| Basic | $ | 0.13 | $ | 0.25 | $ | 0.19 | $ | 0.42 | |||||||||||||||
| Diluted | $ | 0.13 | $ | 0.24 | $ | 0.19 | $ | 0.42 | |||||||||||||||
| Weighted-average number of common shares outstanding | |||||||||||||||||||||||
| Basic | 55,785,622 | 53,006,746 | 55,658,946 | 53,266,209 | |||||||||||||||||||
| Diluted | 56,579,912 | 53,780,060 | 56,029,069 | 53,742,048 | |||||||||||||||||||
THE VITA COCO COMPANY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(Amounts in thousands)
| Nine Months Ended September 30, | |||||||||||
| 2022 | 2021 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ | 10,624 | $ | 22,409 | |||||||
| Adjustments required to reconcile net income to cash flows from operating activities: | |||||||||||
| Depreciation and amortization | 1,442 | 1,557 | |||||||||
| (Gain)/loss on disposal of equipment | — | 89 | |||||||||
| Bad debt expense | 348 | 20 | |||||||||
| Unrealized (gain)/loss on derivative instruments | (6,416) | (1,250) | |||||||||
| Stock-based compensation | 5,657 | 1,641 | |||||||||
| Impairment loss on long-lived asset | 619 | — | |||||||||
| Noncash lease expense | 963 | — | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | (20,696) | (26,940) | |||||||||
| Inventory | (255) | (15,362) | |||||||||
| Prepaid expenses, net supplier advances, and other assets | (4,433) | (12,766) | |||||||||
| Accounts payable, accrued expenses, and other liabilities | (6,034) | 14,251 | |||||||||
| Net cash provided by (used in) operating activities | (18,181) | (16,351) | |||||||||
| Cash flows from investing activities: | |||||||||||
| Cash paid for property and equipment | (907) | (127) | |||||||||
| Net cash used in investing activities | (907) | (127) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Proceeds from exercise of stock options/warrants | 2,675 | 153 | |||||||||
| Borrowings on credit facility | 22,000 | 16,500 | |||||||||
| Repayments of borrowings on credit facility | (12,500) | (34,000) | |||||||||
| Proceeds from settlement of loan to stockholder | — | 17,700 | |||||||||
| Cash received (paid) on notes payable | (22) | 30,028 | |||||||||
| Cash paid to acquire treasury stock | — | (50,003) | |||||||||
| Cash paid to acquire portion of non-controlling interest | — | (54) | |||||||||
| Net cash provided by (used in) financing activities | 12,153 | (19,676) | |||||||||
| Effects of exchange rate changes on cash and cash equivalents | (544) | (117) | |||||||||
| Net decrease in cash and cash equivalents | (7,479) | (36,271) | |||||||||
| Cash and cash equivalents at beginning of the period | 28,690 | 72,181 | |||||||||
| Cash and cash equivalents at end of the period | $ | 21,211 | $ | 35,910 | |||||||
RECONCILIATION FROM GAAP NET INCOME TO NON-GAAP ADJUSTED EBITDA
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||
(in thousands) | ||||||||||||||||||||
| Net income | $ | 7,258 | $ | 12,987 | $ | 10,624 | $ | 22,409 | ||||||||||||
| Depreciation and amortization | 497 | 514 | 1,442 | 1,557 | ||||||||||||||||
| Interest income | (20) | (31) | (30) | (104) | ||||||||||||||||
| Interest expense | 130 | 127 | 213 | 319 | ||||||||||||||||
| Income tax expense | 1,836 | 2,296 | 3,011 | 6,277 | ||||||||||||||||
| EBITDA | 9,701 | 15,893 | 15,260 | 30,458 | ||||||||||||||||
| Stock-based compensation (a) | 1,457 | 629 | 5,657 | 1,641 | ||||||||||||||||
| Unrealized (gain)/loss on derivative instruments (b) | (952) | 1,964 | (6,416) | (1,250) | ||||||||||||||||
| Foreign currency (gain)/loss (b) | 364 | 483 | 508 | 2,013 | ||||||||||||||||
| Other adjustments (c) | 1,240 | 1,678 | 1,240 | 3,401 | ||||||||||||||||
| Adjusted EBITDA | $ | 11,810 | $ | 20,647 | $ | 16,249 | $ | 36,263 | ||||||||||||
(a)Non-cash charges related to stock-based compensation, which vary from period to period depending on volume and vesting timing of awards. We adjusted for these charges to facilitate comparison from period to period.
(b)Unrealized gains or losses on derivative instruments and foreign currency gains or losses are not considered in our evaluation of our ongoing performance.
(c)Reflects other charges inclusive of legal costs, an impairment loss related to assets held for sale, and other non-recurring expenses (including costs related to public company readiness preparation).
SUPPLEMENTAL INFORMATION
NET SALES | |||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Americas segment | |||||||||||||||||||||||
Vita Coco Coconut Water | $ | 82,643 | $ | 71,825 | $ | 217,934 | $ | 176,229 | |||||||||||||||
Private Label | 24,786 | 25,973 | 68,413 | 66,457 | |||||||||||||||||||
Other | 1,367 | 3,135 | 7,553 | 8,246 | |||||||||||||||||||
Subtotal | 108,796 | 100,933 | 293,900 | 250,932 | |||||||||||||||||||
International segment | |||||||||||||||||||||||
Vita Coco Coconut Water | 10,637 | 10,093 | 30,110 | 26,445 | |||||||||||||||||||
Private Label | 3,810 | 4,117 | 9,521 | 9,648 | |||||||||||||||||||
Other | 800 | 526 | 2,265 | 5,904 | |||||||||||||||||||
Subtotal | 15,247 | 14,736 | 41,896 | 41,997 | |||||||||||||||||||
Total net sales | $ | 124,043 | $ | 115,669 | $ | 335,796 | $ | 292,929 | |||||||||||||||
COST OF GOODS SOLD & GROSS PROFIT | |||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Cost of goods sold | |||||||||||||||||||||||
Americas segment | 78,516 | 66,254 | 220,615 | 169,430 | |||||||||||||||||||
International segment | 12,951 | 10,914 | 34,253 | 31,938 | |||||||||||||||||||
Total cost of goods sold | $ | 91,467 | $ | 77,168 | $ | 254,868 | $ | 201,368 | |||||||||||||||
Gross profit | |||||||||||||||||||||||
Americas segment | 30,279 | 34,679 | 73,285 | 81,502 | |||||||||||||||||||
International segment | 2,297 | 3,822 | 7,643 | 10,059 | |||||||||||||||||||
Total gross profit | $ | 32,576 | $ | 38,501 | $ | 80,928 | $ | 91,561 | |||||||||||||||
Gross margin | |||||||||||||||||||||||
Americas segment | 27.8 | % | 34.4 | % | 24.9 | % | 32.5 | % | |||||||||||||||
International segment | 15.1 | % | 25.9 | % | 18.2 | % | 24.0 | % | |||||||||||||||
Consolidated | 26.3 | % | 33.3 | % | 24.1 | % | 31.3 | % | |||||||||||||||
SUPPLEMENTAL INFORMATION
| VOLUME (CE) | |||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| (in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
| Americas segment | |||||||||||||||||||||||
| Vita Coco Coconut Water | 8,670 | 7,605 | 23,269 | 19,482 | |||||||||||||||||||
| Private Label | 2,346 | 2,934 | 7,213 | 7,643 | |||||||||||||||||||
| Other | 200 | 326 | 1,092 | 831 | |||||||||||||||||||
| Subtotal | 11,216 | 10,865 | 31,574 | 27,956 | |||||||||||||||||||
| International segment* | |||||||||||||||||||||||
| Vita Coco Coconut Water | 1,581 | 1,463 | 4,412 | 3,890 | |||||||||||||||||||
| Private Label | 492 | 540 | 1,326 | 1,327 | |||||||||||||||||||
| Other | 13 | 7 | 38 | 213 | |||||||||||||||||||
| Subtotal | 2,086 | 2,010 | 5,776 | 5,430 | |||||||||||||||||||
| Total volume (CE) | 13,302 | 12,875 | 37,350 | 33,386 | |||||||||||||||||||
Note: A CE is a standard volume measure used by management which is defined as a case of 12 bottles of 330ml liquid beverages or the same liter volume of oil.
*International Other excludes minor volume that is treated as zero CE